Alexion Pharmaceuticals Inc. Joins National Organization for Rare Disorders and EURORDIS in Supporting the Goals of Rare Disease Day

CHESHIRE, Conn. & PARIS--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc., (Nasdaq: ALXN) has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the second annual Rare Disease Day, February 28, 2009. Rare Disease Day seeks to increase the visibility of rare diseases, give hope and information to patients, coordinate policy actions in different countries, and ensure equal access to quality care and treatment.